Measures of psychiatric symptoms in Alzheimer patients

A review

Myron F. Weiner, Elisabeth Koss, Katherine Wild, David G. Folks, Pierre Tariot, Halina Luszczynska, Peter Whitehouse

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

This review of instruments for the identification and quantification of psychiatric symptoms in Alzheimer disease (AD) is intended as a reference source for clinicians and researchers concerned with evaluating, quantifying, and managing psychiatric symptoms in AD. We review 16 clinician- and caregiver-rated scales selected from > 30 scales on the basis of their face validity, their psychometric properties, the frequency of their use, and their promise as assessment instruments. Instruments are described in terms of the population on which they were developed, the symptoms assessed, informant, by whom administered time to administer, time interval covered, number of items, measurement of frequency and severity, assessment of impact on caregiver, reliability, validity, and scoring. Recommendations are made concerning the best use of each scale. We summarize in table form the sources of information for instruments, characteristics of the instruments by domain, and potential use of instruments for quantification or management of symptoms and for estimation of caregiver burden. There are a number of reliable and valid scales for the assessment of psychiatric symptoms in AD, each with specific assets and liabilities. Knowledge of the specifics of these scales will enable clinicians and researchers to select the best instruments for their particular needs and to design more effective instruments.

Original languageEnglish (US)
Pages (from-to)20-30
Number of pages11
JournalAlzheimer Disease and Associated Disorders
Volume10
Issue number1
DOIs
StatePublished - 1996

Fingerprint

Caregivers
Psychiatry
Alzheimer Disease
Reproducibility of Results
Research Personnel
Symptom Assessment
Psychometrics
Population

Keywords

  • Alzheimer disease
  • Psychiatric symptoms

ASJC Scopus subject areas

  • Geriatrics and Gerontology
  • Psychiatry and Mental health
  • Neuroscience(all)

Cite this

Weiner, M. F., Koss, E., Wild, K., Folks, D. G., Tariot, P., Luszczynska, H., & Whitehouse, P. (1996). Measures of psychiatric symptoms in Alzheimer patients: A review. Alzheimer Disease and Associated Disorders, 10(1), 20-30. https://doi.org/10.1097/00002093-199601010-00005

Measures of psychiatric symptoms in Alzheimer patients : A review. / Weiner, Myron F.; Koss, Elisabeth; Wild, Katherine; Folks, David G.; Tariot, Pierre; Luszczynska, Halina; Whitehouse, Peter.

In: Alzheimer Disease and Associated Disorders, Vol. 10, No. 1, 1996, p. 20-30.

Research output: Contribution to journalArticle

Weiner, MF, Koss, E, Wild, K, Folks, DG, Tariot, P, Luszczynska, H & Whitehouse, P 1996, 'Measures of psychiatric symptoms in Alzheimer patients: A review', Alzheimer Disease and Associated Disorders, vol. 10, no. 1, pp. 20-30. https://doi.org/10.1097/00002093-199601010-00005
Weiner, Myron F. ; Koss, Elisabeth ; Wild, Katherine ; Folks, David G. ; Tariot, Pierre ; Luszczynska, Halina ; Whitehouse, Peter. / Measures of psychiatric symptoms in Alzheimer patients : A review. In: Alzheimer Disease and Associated Disorders. 1996 ; Vol. 10, No. 1. pp. 20-30.
@article{ea39951d51814035bac276a5f8f495a1,
title = "Measures of psychiatric symptoms in Alzheimer patients: A review",
abstract = "This review of instruments for the identification and quantification of psychiatric symptoms in Alzheimer disease (AD) is intended as a reference source for clinicians and researchers concerned with evaluating, quantifying, and managing psychiatric symptoms in AD. We review 16 clinician- and caregiver-rated scales selected from > 30 scales on the basis of their face validity, their psychometric properties, the frequency of their use, and their promise as assessment instruments. Instruments are described in terms of the population on which they were developed, the symptoms assessed, informant, by whom administered time to administer, time interval covered, number of items, measurement of frequency and severity, assessment of impact on caregiver, reliability, validity, and scoring. Recommendations are made concerning the best use of each scale. We summarize in table form the sources of information for instruments, characteristics of the instruments by domain, and potential use of instruments for quantification or management of symptoms and for estimation of caregiver burden. There are a number of reliable and valid scales for the assessment of psychiatric symptoms in AD, each with specific assets and liabilities. Knowledge of the specifics of these scales will enable clinicians and researchers to select the best instruments for their particular needs and to design more effective instruments.",
keywords = "Alzheimer disease, Psychiatric symptoms",
author = "Weiner, {Myron F.} and Elisabeth Koss and Katherine Wild and Folks, {David G.} and Pierre Tariot and Halina Luszczynska and Peter Whitehouse",
year = "1996",
doi = "10.1097/00002093-199601010-00005",
language = "English (US)",
volume = "10",
pages = "20--30",
journal = "Alzheimer Disease and Associated Disorders",
issn = "0893-0341",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Measures of psychiatric symptoms in Alzheimer patients

T2 - A review

AU - Weiner, Myron F.

AU - Koss, Elisabeth

AU - Wild, Katherine

AU - Folks, David G.

AU - Tariot, Pierre

AU - Luszczynska, Halina

AU - Whitehouse, Peter

PY - 1996

Y1 - 1996

N2 - This review of instruments for the identification and quantification of psychiatric symptoms in Alzheimer disease (AD) is intended as a reference source for clinicians and researchers concerned with evaluating, quantifying, and managing psychiatric symptoms in AD. We review 16 clinician- and caregiver-rated scales selected from > 30 scales on the basis of their face validity, their psychometric properties, the frequency of their use, and their promise as assessment instruments. Instruments are described in terms of the population on which they were developed, the symptoms assessed, informant, by whom administered time to administer, time interval covered, number of items, measurement of frequency and severity, assessment of impact on caregiver, reliability, validity, and scoring. Recommendations are made concerning the best use of each scale. We summarize in table form the sources of information for instruments, characteristics of the instruments by domain, and potential use of instruments for quantification or management of symptoms and for estimation of caregiver burden. There are a number of reliable and valid scales for the assessment of psychiatric symptoms in AD, each with specific assets and liabilities. Knowledge of the specifics of these scales will enable clinicians and researchers to select the best instruments for their particular needs and to design more effective instruments.

AB - This review of instruments for the identification and quantification of psychiatric symptoms in Alzheimer disease (AD) is intended as a reference source for clinicians and researchers concerned with evaluating, quantifying, and managing psychiatric symptoms in AD. We review 16 clinician- and caregiver-rated scales selected from > 30 scales on the basis of their face validity, their psychometric properties, the frequency of their use, and their promise as assessment instruments. Instruments are described in terms of the population on which they were developed, the symptoms assessed, informant, by whom administered time to administer, time interval covered, number of items, measurement of frequency and severity, assessment of impact on caregiver, reliability, validity, and scoring. Recommendations are made concerning the best use of each scale. We summarize in table form the sources of information for instruments, characteristics of the instruments by domain, and potential use of instruments for quantification or management of symptoms and for estimation of caregiver burden. There are a number of reliable and valid scales for the assessment of psychiatric symptoms in AD, each with specific assets and liabilities. Knowledge of the specifics of these scales will enable clinicians and researchers to select the best instruments for their particular needs and to design more effective instruments.

KW - Alzheimer disease

KW - Psychiatric symptoms

UR - http://www.scopus.com/inward/record.url?scp=0029958868&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029958868&partnerID=8YFLogxK

U2 - 10.1097/00002093-199601010-00005

DO - 10.1097/00002093-199601010-00005

M3 - Article

VL - 10

SP - 20

EP - 30

JO - Alzheimer Disease and Associated Disorders

JF - Alzheimer Disease and Associated Disorders

SN - 0893-0341

IS - 1

ER -